TranS1 Inc. (TSON) has announced that it expects revenues to be approximately $6.8 million to $6.9 million in the third quarter of 2009 compared to $6 million reported in the year-ago quarter. Results for the quarter are expected to be released on Oct 29, 2009.

While revenues are expected to increase from the year-ago period, they are still predicted to be lower than the previous guidance of $7.4 million to $7.9 million. The lower guidance is primarily based on weak sales of the company’s AxiaLIF lumbar fusion device due to insurance reimbursement concerns.

However, management considers these low revenues as a short-term event and is confident about long-term growth primarily due to the expanding minimally invasive spine surgery market.

TranS1 is working on educating existing and potential customers about the utilities of the AxiaLIF lumbar fusion device to increase its sales. The device allows surgeons access to the lumbar vertebrae, thereby enabling them to perform fusion operations without cutting through muscle or ligaments.

TranS1 is a medical device company focused on designing, developing and marketing products that use its proprietary minimally invasive surgical approach to treat degenerative disc disease affecting the lower lumbar region of the spine. It currently markets two single-level fusion products, AxiaLIF and AxiaLIF 360°, and a two-level fusion product, the AxiaLIF 2L, in the US and Europe.

Founded in May 2000 and headquartered in Wilmington, North Carolina, TranS1 competes mainly with Stryker Corp. (SYK).

Zacks Investment Research
View original at: Zacks.com News Feed

1. (ETR) Entergy Trims Third Quarter OutlookEntergy Corporation (ETR) earlier today announced that it expects GAAP earnings and operational earnings to...
2. (COP) ConocoPhillips Hikes Dividend, Trims CapexConocoPhillips (COP) on Wednesday said it will increase its quarterly dividend by 6% to 50...
3. (IART) Integra LifeSciences Holdings Launches New ProductIntegra LifeSciences Holdings Corporation (IART) recently launched a smaller configuration of the innovative Accell Evo3...
4. (MDT) Integra LifeSciences Holdings Buys Bankrupt RivalYesterday, Integra LifeSciences Holdings Corp. (IART) announced that it purchased almost all the assets of...
5. (EMC) EMC’s Results Above Expectations – fourth quarter is expected to be the strongest quarter of the yearEMC Corp.’s (EMC) second quarter results were better than analysts’ expectations. Although results were down...
6. (TSO) Tesoro Outlook Bearish – second-quarter loss of 33 cents per shareOur Underperform recommendation on Tesoro (TSO) shares takes into account the bearish refining margin outlook....

Search Posts by Tag: Stryker Corporation | SYK | TranS1 Inc | TSON | Healthcare

RSS Feeds by Tag: Stryker Corporation | SYK | TranS1 Inc | TSON | Healthcare |

Other Posts by: vitalstocks | RSS Feed for this author